Department of Veterinary Disease Biology, Faculty of Life Sciences, University of Copenhagen is offering a PhD project commencing 1/1 2011 or soon thereafter. The application deadline is December 1st 2010.
The Faculty of Life Science and Novo Nordisk A/S have recently established a research centre - The Novo Nordisk-LIFE In Vivo Pharmacology Centre (NNLIVPC) - with a total budget of DKK 68 mill covering activities until end 2018. The present positions are part of the new Centre´s activities. The purpose of the research centre is to strengthen the research in experimental pharmacology and toxicology and to increase the output of candidates and PhDs with a strong in vivo pharmacological profile. It is expected that the future PhD fellows will be enrolled in the In Vivo Pharmacology PhD program at LIFE and participate actively in this network. The In Vivo Pharmacology PhD program was established in 2006 as a collaboration between the Faculties of Life Sciences, Pharmaceutical Sciences and Health Sciences at the University of Copenhagen, University of Aarhus, and industrial partners; Novo Nordisk A/S, LEO Pharma and H. Lundbeck A/S.
Obesity, increased visceral fat mass, and liver steatosis (fat in liver) are factors associated with increased risk of developing cardiovascular disease. A common side effect following insulin therapy is weight gain - an issue for patients with type 2 diabetes as they often are obese when starting on insulin therapy. At present, the association between insulin-induced weight gain in type 2 diabetic individuals and the risk of developing cardiovascular disease is unclear.
With this project we wish to i) establish how insulin-induced obesity is associated with visceral fat mass and liver steatosis in an animal model of type 2 diabetes, ii) investigate how such changes are associated with relevant blood and tissue markers of inflammation and cardiovascular disease, and iii) investigate how insulin-induced weight gain in patients with type 2 diabetes is associated with changes in markers of cardiovascular disease.Contact:
Professor Jens Lykkesfeldt
Direct Phone: (+45) 35333163
Ph D Position In Cardiovascular Toxicity (Fixed Term), University of Cambridge, United Kingdom, 9 days ago
Applications are invited for a fully-funded PhD position for Home (UK)/EU students in the Department of Pharmacology at the University of Cambridge. The studentship is fully funded by AstraZeneca ...
Ph D Scholarship For Research Into Cardiovascular Disease Inequalities », Australian National University, Australia, 3 days ago
Overview The National Centre for Epidemiology and Population Health (NCEPH) is offering the opportunity to join a high-performing, collegial team as a postgraduate scholar for a period of approxim...
Ph D Studentship: The Role Of Immune Modulation And Tolerance In Pneumococcal Carriage And Invasive Disease, University of Liverpool, United Kingdom, 17 days ago
Name of supervisor(s) Dr. Daniel Neill Prof. Aras Kadioglu Title of research project The role of immune modulation and tolerance in pneumococcal carriage and invasive disease. Short outline of res...
Postgraduate Scholarship In Epigenetic Regulation Of Mi Rna Expression In Diabetes, University of Sydney, Australia, 11 days ago
Funding Body: University of Sydney Title: Postgraduate Scholarship in Epigenetic regulation of miRNA expression in diabetes Research Areas: Health Sciences Type Postgraduate Research Description: ...
Ph D Positions, Inserm Unit 1110, France, 6 days ago
Marie Curie Actions Co-fund. More Marie Curie Actions. More European Research Council. More 'HR Excellence in Research' logo awarded to institutions actively implementing the European Charter and ...
Mrc Ittp Ph D Studentship (Fixed Term), University of Cambridge, United Kingdom, 18 days ago
Molecular mechanisms of bile salt export pump (BSEP) inhibition in drug-induced liver injury An exciting opportunity has arisen for a PhD student to work on a project funded by the MRC Integrative...